Journal
ATHEROSCLEROSIS
Volume 207, Issue 2, Pages 428-433Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2009.05.021
Keywords
Atherosclerosis; MIF; NF-kappa B; oxLDL; VSMCs
Funding
- Natural Science Foundation [30725033, 30530340]
- Ministry of Science and Technology [2006CB503907]
Ask authors/readers for more resources
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine playing important roles in atherosclerosis. MIF gene deficiency and neutralizing antibodies against MIF have been reported to exert anti-atherosclerotic effects in various animal models. However, the mechanism by which MIF is induced in atherosclerotic lesions remains unclear. In the present studies, we cloned a 540 bp full-length rabbit MIF cDNA by screening a rabbit uterine library. The cDNA contains a 348 bp open-reading frame which encodes a deduced 115-amino acid polypeptide with similar to 90% similarity to human and mouse homologs. Constitutive MIF mRNA expression was detected in most rabbit tissues including aortas. The expression of MIF obviously abounded in vascular smooth muscle cells (VSMCs) of the atherosclerotic plaques. In cultured VSMCs, MIF expression was significantly induced by a pro-atherogenic factor, oxidized low-density lipoprotein (oxLDL). Promoter analysis showed there were two NF-kappa B binding sites in the MIF proximal promoter region. Deletion or mutation of the two sites abolished oxLDL-enhanced MIF promoter activity. Moreover, the induction of MIF by oxLDL can be blocked by I kappa B-alpha overexpression. Taken together, our results revealed that MIF expression can be induced by oxLDL in VSMCs via a NF-kappa B dependent manner, which may contribute to the pathogenesis of atherosclerosis. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available